Skip to main content
Equibles
ICUI logo

ICUI · Icu Medical Inc/De

Track ICUI — free

Use ICUI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ICUI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$182.98 -0.13 (-0.07%) At close · Aug 14
Customer concentration — top customer 19% of revenue

One customer — 19% of revenue (the six months ended June 30, 2026)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 19% of revenue (the three months ended June 30, 2026)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 19% of revenue (the three months ended June 30, 2025)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 18% of revenue (the six months ended June 30, 2025)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”
View the 10-Q filed Aug 6, 2026
Market Cap
$4.58B
Shares
25.01M

Icu Medical Inc Earnings Call Transcripts

Every quarterly earnings call for Icu Medical Inc (ICUI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲77.9% $597.86M −$9.81M '22 Q3 22-11-07 ▲69.7% $578.01M −$18.93M '22 Q4 23-02-27 ▲4.7% $568.65M −$9.81M '23 Q1 23-05-08 ▼2.1% $549.31M −$9.93M '23 Q2 23-08-07 ▼7.5% $553.31M $7.24M '23 Q3 23-11-06 ▲1.7% $587.86M −$17.15M '23 Q4 24-02-27 ▼0.4% $566.65M −$39.47M '24 Q1 24-05-07 ▲8.6% $596.46M −$21.41M '24 Q2 24-08-07 ▲6.5% $589.13M −$32.98M '24 Q3 24-11-12 ▲7.1% $629.80M −$23.83M '24 Q4 25-02-27 ▲6.7% $604.70M −$15.48M '25 Q1 25-05-08 ▼8% $548.87M $35.34M '25 Q2 25-08-07 ▼8.9% $536.99M −$3.40M '25 Q3 25-11-06 ▼14.1% $540.70M −$15.73M '25 Q4 26-02-19 ▼12.3% $530.23M $30.13M '26 Q1 26-05-07 LATEST ▲0.5% $551.68M $19.09M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
ICU Medical, Inc. Second Quarter 2026 Earnings Conference Call
Balanced tone Vital care weakness Tariffs and refunds Consumables business performance
Revenue
$551.68M
▲ 0.5% YoY
Diluted EPS
$0.76
▼ 46.9% YoY
Gross margin
42.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Icu Medical Inc/De Q1 FY2026 Earnings Call
Balanced tone Consumables growth FDA pump hardware delays Guidance reiteration
Revenue
$530.23M
▼ 12.3% YoY
Diluted EPS
$1.20
Gross margin
38.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-04-13
25th Annual Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-19
Icu Medical Inc/De Q4 FY2025 Earnings Call
Confident tone Gross margin and free cash flow improvement Consumables growth IV systems / pumps
Revenue
$540.70M*
▼ 14.1% YoY
Gross margin
37.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Icu Medical Inc/De Q3 FY2025 Earnings Call
Positive tone Free cash flow and remediation costs Consumables growth Portfolio optimization / M&A exploration
Revenue
$536.99M
▼ 8.9% YoY
Diluted EPS
$-0.14
Gross margin
37.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Icu Medical Inc/De Q2 FY2025 Earnings Call
Positive tone IV Solutions joint venture and Vital Care Tariffs and Costa Rica Consumables growth and Clave 510(k) clearance
Revenue
$548.87M
▼ 8% YoY
Diluted EPS
$1.43
Gross margin
37.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Icu Medical Inc/De Q1 FY2025 Earnings Call
Positive tone Tariffs Innovation and Quality Quarterly Revenue and Earnings Performance
Revenue
$604.70M
▲ 6.7% YoY
Diluted EPS
$-0.63
Gross margin
34.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Icu Medical Inc/De Q4 FY2024 Earnings Call
Positive tone IV Solutions shortage and demand Consumables segment performance Currency headwinds
Revenue
$629.80M*
▲ 7.1% YoY
Gross margin
36.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Icu Medical Inc/De Q3 FY2024 Earnings Call
Positive tone IV Solutions / Otsuka Joint Venture Competitive Dynamics in Pump Market Capital, Cash Flow and Balance Sheet
Revenue
$589.13M
▲ 6.5% YoY
Diluted EPS
$-1.35
▼ 550% YoY
Gross margin
34.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Icu Medical Inc/De Q2 FY2024 Earnings Call
Positive tone Integration, consolidation, and operational improvements Profitability and margin expansion Cash generation and debt paydown
Revenue
$596.46M
▲ 8.6% YoY
Diluted EPS
$-0.88
Gross margin
34.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Icu Medical Inc/De Q1 FY2024 Earnings Call
Positive tone Gross margin and supply chain Integration, consolidation and synergy capture FX and macro headwinds
Revenue
$566.65M
▼ 0.4% YoY
Diluted EPS
$-1.63
Gross margin
32.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Icu Medical Inc/De Q4 FY2023 Earnings Call
Positive tone Inventory and cash flow Gross margin and 2024 guidance Quality remediation and integration
Revenue
$587.86M*
▲ 1.7% YoY
Gross margin
29.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Icu Medical Inc/De Q3 FY2023 Earnings Call
Revenue
$553.31M
▼ 7.5% YoY
Diluted EPS
$0.30
Gross margin
33.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Icu Medical Inc/De Q2 FY2023 Earnings Call
Revenue
$549.31M
▼ 2.1% YoY
Diluted EPS
$-0.41
Gross margin
35.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Icu Medical Inc/De Q1 FY2023 Earnings Call
Revenue
$568.65M
▲ 4.7% YoY
Diluted EPS
$-0.41
Gross margin
33.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-27
Icu Medical Inc/De Q4 FY2022 Earnings Call
Revenue
$578.01M*
▲ 69.7% YoY
Gross margin
30.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Icu Medical Inc/De Q3 FY2022 Earnings Call
Revenue
$597.86M
▲ 77.9% YoY
Diluted EPS
$-0.55
▼ 138.5% YoY
Gross margin
31.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Icu Medical Inc/De Q2 FY2022 Earnings Call
Revenue
$561.00M
▲ 74.4% YoY
Diluted EPS
$-0.31
▼ 123.7% YoY
Gross margin
29.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Icu Medical Inc/De Q1 FY2022 Earnings Call
Revenue
$543.12M
▲ 70.8% YoY
Diluted EPS
$-1.61
▼ 247.7% YoY
Gross margin
31.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Icu Medical Inc/De Q4 FY2021 Earnings Call
Revenue
$340.52M*
▲ 6.3% YoY
Gross margin
37.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Icu Medical Inc/De Q3 FY2021 Earnings Call
Revenue
$336.06M
▲ 5.5% YoY
Diluted EPS
$1.43
▲ 23.3% YoY
Gross margin
38.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Icu Medical Inc/De Q2 FY2021 Earnings Call
Revenue
$321.68M
▲ 6% YoY
Diluted EPS
$1.31
▲ 48.9% YoY
Gross margin
38.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Icu Medical Inc/De Q1 FY2021 Earnings Call
Revenue
$318.05M
▼ 3.2% YoY
Diluted EPS
$1.09
▲ 39.7% YoY
Gross margin
35.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Icu Medical Inc/De Q4 FY2020 Earnings Call
Revenue
$320.45M
▲ 1.6% YoY
Diluted EPS
$1.21
▲ 26% YoY
Gross margin
37.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Icu Medical Inc/De Q3 FY2020 Earnings Call
Revenue
$318.57M
▲ 3.6% YoY
Diluted EPS
$1.16
▼ 6.5% YoY
Gross margin
35.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Icu Medical Inc/De Q2 FY2020 Earnings Call
Revenue
$303.38M
▼ 2.9% YoY
Diluted EPS
$0.88
▼ 17% YoY
Gross margin
35.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Icu Medical Inc/De Q1 FY2020 Earnings Call
Revenue
$328.61M
▼ 0.7% YoY
Diluted EPS
$0.78
▼ 45.8% YoY
Gross margin
36.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Icu Medical Inc/De Q4 FY2019 Earnings Call
Revenue
$315.52M
▼ 7.3% YoY
Diluted EPS
$0.96
Gross margin
36.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 earnings calls
Key facts CIK 883984 CUSIP 44930G107 13F (30d) 263 filings 262 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)